Home » Topics » BioWorld Science

BioWorld Science
RSS

PACAP27 identified as a novel target for the treatment of migraine

Aug. 27, 2019

Positive topline results from pivotal phase III ORION-11 study of inclisiran

Aug. 27, 2019

FDA grants approval for Taltz as treatment of active ankylosing spondylitis

Aug. 27, 2019

New potent vanin-1 inhibitor as preclinical candidate for inflammatory bowel disease

Aug. 27, 2019

Tuberculosis vaccine MTBVAC shows promise in phase I/II trial in adults and infants

Aug. 27, 2019

CD40-targeting peptide KGYY-6 may ameliorate multiple sclerosis

Aug. 27, 2019

Chromatin problem linked to accelerated aging

Aug. 27, 2019

EA-230 attenuates the systemic inflammatory response in humans

Aug. 27, 2019

Mouse model of 8-OH-DPAT-induced compulsive-like responses confirms the key role of 5-HT

Aug. 27, 2019

Phase III BREEZE-AD7 study of baricitinib in atopic dermatitis meets primary endpoint

Aug. 26, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...